ClinConnect ClinConnect Logo
Search / Trial NCT06679478

Evaluation of Early Mobilization Protocol in Patients Undergoing Gastrointestinal Surgery

Launched by ULUDAG UNIVERSITY · Nov 5, 2024

Trial Information

Current as of July 22, 2025

Enrolling by invitation

Keywords

Gastrointestinal Diseases Enhanced Recovery After Surgery Early Ambulation

ClinConnect Summary

This study is an experimental study. The participants in the control group are applied to the mobilization applied in routine clinics. The participants in the intervention group are applied to the mobilization protocol created in accordance with the Enhanced Recovery After Surgery (ERAS) guidelines. It is planned to evaluate the postoperative mobilization process of both groups.

In this study, the researchers aimed to evaluate the early mobilization protocol created in accordance with the accelerated recovery guide after surgery in patients undergoing gastrointestinal surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being 18 years of age or older
  • Agreeing to participate in the study
  • Being able to understand, speak Turkish or have no obstacle to communication
  • Having undergone open gastrointestinal surgery
  • Having an American Society of Anesthesiologists (ASA) score \<IV
  • Being fully independent according to the Modified Barthel Index during the pre-operative period
  • Staying in the hospital for at least 48 hours after the surgery
  • Having a phone
  • Agreeing to download the 'StepsApp Pedometer' application to their phone
  • Agreeing to carry the phone with them during the post-operative mobilization processes
  • Exclusion Criteria:
  • Being taken into emergency surgery
  • Having had major gastrointestinal surgery before
  • Having a diagnosis that may restrict mobilization (neurological, cardiovascular, respiratory and musculoskeletal comorbidities)
  • High risk of falling in the preoperative period
  • Using medication that may affect mobilization
  • Having a diagnosis of any psychiatric disease
  • Having a Nutritional Risk Score score of ≥3
  • Being in contact isolation
  • Being morbidly obese
  • Being in intensive care for more than 24 hours during the postoperative period
  • Having an intubation period of more than 24 hours during the postoperative period
  • Developing a complication that may prevent mobilization after surgery
  • Withdrawing from participating in the study,

About Uludag University

Uludağ University is a leading academic institution located in Bursa, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Uludağ University leverages its extensive expertise and resources to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university's collaborative approach fosters partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring rigorous adherence to ethical standards and regulatory guidelines. Through its clinical trials, Uludağ University aims to contribute significantly to the scientific community and enhance the understanding of various medical conditions and treatments.

Locations

Kütahya, , Turkey

Patients applied

0 patients applied

Trial Officials

Derya Şayır Köksal, Lecturer

Principal Investigator

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported